WFSBP Guidelines on Brain Stimulation Treatments in Psychiatry

Thomas E. Schläepfer; Mark S. George; Helen Mayberg

doi:10.3109/15622970903170835

WFSBP Guidelines on Brain Stimulation Treatments in Psychiatry

Thomas E. Schläepfer
, Mark S. George
, Helen Mayberg

Research output: Contribution to journal › Review article › peer-review

103 Scopus citations

Original language	English
Pages (from-to)	2-18
Number of pages	17
Journal	World Journal of Biological Psychiatry
Volume	11
Issue number	1
DOIs	https://doi.org/10.3109/15622970903170835
State	Published - 2010
Externally published	Yes

Access to Document

10.3109/15622970903170835

Cite this

@article{4c63e4ab283c43a8aa64807bcfbd37bb,

title = "WFSBP Guidelines on Brain Stimulation Treatments in Psychiatry",

author = "Schl{\"a}epfer, \{Thomas E.\} and George, \{Mark S.\} and Helen Mayberg",

note = "Funding Information: Dr George has no equity ownership in any device or pharmaceutical company and his total industry-related compensation per year is less than 10\% of his university salary. His institution, MUSC has filed eight patents or invention disclosures in his name regarding brain imaging and stimulation. He is the study chair of a large NIMH sponsored trial of TMS in depression (called OPT-TMS) and is on the executive committee of a large veterans administration (VA) trial of TMS in Depression (CSP\#556). He thus has received no compensation from any TMS manufacturer for the last 4 years, but is an unpaid consultant to Neuronetics, Brainsway, and Neostim, as well as PureTech Ventures. MUSC is a site in a multisite Brainsway sponsored trial. Neu-ronetics has donated equipment for an investigator initiated VA trial of TMS in acute suicide. Dr George has been a paid consultant or received research grants from Cyberonics (VNS) and Neuropace (DBS), but not in the past year. Medtronic donated equipment for an investigator-initiated trial of epidural cortical stimulation conducted at MUSC (PI, Dr Nahas). Within the past 3 years he has received industry support for two TMS studies investigating the effects of medications on brain excitability (Jazz pharmaceuticals, Glaxo Smith Kline). He is the editor in chief of an Elsevier sponsored journal, Brain Stimulation. He is currently funded by NIMH, NIDA, VA and DOD.",

year = "2010",

doi = "10.3109/15622970903170835",

language = "English",

volume = "11",

pages = "2--18",

journal = "World Journal of Biological Psychiatry",

issn = "1562-2975",

publisher = "Taylor and Francis Ltd.",

number = "1",

}

TY - JOUR

T1 - WFSBP Guidelines on Brain Stimulation Treatments in Psychiatry

AU - Schläepfer, Thomas E.

AU - George, Mark S.

AU - Mayberg, Helen

N1 - Funding Information: Dr George has no equity ownership in any device or pharmaceutical company and his total industry-related compensation per year is less than 10% of his university salary. His institution, MUSC has filed eight patents or invention disclosures in his name regarding brain imaging and stimulation. He is the study chair of a large NIMH sponsored trial of TMS in depression (called OPT-TMS) and is on the executive committee of a large veterans administration (VA) trial of TMS in Depression (CSP#556). He thus has received no compensation from any TMS manufacturer for the last 4 years, but is an unpaid consultant to Neuronetics, Brainsway, and Neostim, as well as PureTech Ventures. MUSC is a site in a multisite Brainsway sponsored trial. Neu-ronetics has donated equipment for an investigator initiated VA trial of TMS in acute suicide. Dr George has been a paid consultant or received research grants from Cyberonics (VNS) and Neuropace (DBS), but not in the past year. Medtronic donated equipment for an investigator-initiated trial of epidural cortical stimulation conducted at MUSC (PI, Dr Nahas). Within the past 3 years he has received industry support for two TMS studies investigating the effects of medications on brain excitability (Jazz pharmaceuticals, Glaxo Smith Kline). He is the editor in chief of an Elsevier sponsored journal, Brain Stimulation. He is currently funded by NIMH, NIDA, VA and DOD.

PY - 2010

Y1 - 2010

UR - https://www.scopus.com/pages/publications/76549260974

U2 - 10.3109/15622970903170835

DO - 10.3109/15622970903170835

M3 - Review article

C2 - 20146648

AN - SCOPUS:76549260974

SN - 1562-2975

VL - 11

SP - 2

EP - 18

JO - World Journal of Biological Psychiatry

JF - World Journal of Biological Psychiatry

IS - 1

ER -